Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
6.79
+0.04 (0.59%)
At close: Sep 4, 2026, 4:00 PM EDT
6.92
+0.13 (1.98%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Cumberland Pharmaceuticals Employees
Cumberland Pharmaceuticals had 88 employees as of June 30, 2026. The number of employees decreased by 5 or -5.38% since the number was reported on December 31, 2025.
Employees
88
Change
-5
Growth
-5.38%
Revenue / Employee
$503,458
Profits / Employee
-$124,074
Market Cap
101.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 88 | -5 | -5.38% |
| Dec 31, 2025 | 93 | 2 | 2.20% |
| Dec 31, 2024 | 91 | 0 | - |
| Dec 31, 2023 | 91 | 6 | 7.06% |
| Dec 31, 2022 | 85 | 2 | 2.41% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 382 |
| InterCure | 285 |
| Zhengye Biotechnology Holding | 269 |
| ADC Therapeutics | 193 |
| Journey Medical | 58 |
| SCYNEXIS | 18 |
CPIX News
- 4 weeks ago - CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS - PRNewsWire
- 4 weeks ago - Cumberland Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Cumberland Pharmaceuticals Earnings release: Q2 2026 - Filings
- 4 weeks ago - Cumberland Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 5 weeks ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS - PRNewsWire
- 1 month ago - Cumberland announces special dividend of $1.50 per share - TheFly
- 1 month ago - Cumberland board authorizes $5M share repurchase program - TheFly
- 1 month ago - CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - PRNewsWire